AYRMID
Live / Allowed — Notice of allowance issued (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99283009
- Mark type
- Stylized text
- Filed
- 14 Jul 2025
- Published for opposition
- 06 Jan 2026
- Attorney of record
- Charles T.J. Weigell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of hematological diseases; pharmaceutical preparations used in hematopoietic transplants; allogenic cell therapy preparations for the prevention and treatment of cancer; pharmaceutical preparations for use in hematology and in tissue and organ transplantation
Owner
- Ayrmid Pharma Ltd, Dublin, IE
- Ayrmid Pharma Ltd, Dublin, IE
Prosecution history
- 03 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jan 2026 — PUBLISHED FOR OPPOSITION
- 31 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
- 10 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
- 02 Dec 2025 — ASSIGNED TO EXAMINER
- 14 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Jul 2025 — NEW APPLICATION ENTERED